Background Highly crosslinked polyethylene (HXLPE) was introduced to reduce wear and osteolysis in total joint arthroplasty. While many studies report wear and osteolysis associated with HXLPE, analytical techniques, clinical study design and followup, HXLPE formulation and implant design characteristics, and patient populations differ substantially among investigations, complicating a unified perspective. Questions/purposes Literature on first-generation HXLPE was summarized. We systematically reviewed the radiographic wear data and incidence of osteolysis for HXLPE in hip and knee arthroplasty. Methods PubMed identified 391 studies; 28 met inclusion criteria for a weighted-averages analysis of two-dimensional femoral head penetration rates. To determine the incidence of osteolysis, we estimated a pooled odds ratio using a random-effects model.
Introduction
Ultrahigh-molecular-weight polyethylene, also known as UHMWPE, polyethylene, or simply ''poly,'' has been an orthopaedic bearing material for total joint arthroplasties since the 1960s [26] . Polyethylene is chemically and conceptually simple, produced by the polymerization of ethylene gas into a macromolecular carbon chain with pendant hydrogen atoms, yet the polyethylene biomaterials in clinical use today, whether crosslinked by gamma or electron beam radiation and annealed or remelted by thermal treatments, are exceedingly more complex than the gamma-air-sterilized polyethylene used up to the 1990s. Even today, the state of knowledge for polyethylene biomaterials continues to evolve, and the number of clinical studies related to polyethylene has increased substantially within the past 5 years.
Not only the polyethylene biomaterials themselves but their clinical applications have expanded since the 1990s. Within the United States, the most widely used clinical application of polyethylene biomaterials today is in knee arthroplasty. For the hip, on the other hand, polyethylene biomaterials are still used in the majority of cases, but hard-on-hard alternatives, including metal-on-metal and ceramic-on-ceramic, have emerged as potential alternatives for younger, higher-demand patients. Thus, polyethylene biomaterials remain the material of choice for knee arthroplasty; however, considerable debate continues regarding the selection of alternative bearings for the hip.
Highly crosslinked and thermally treated polyethylenes (HXLPEs) were clinically introduced starting in 1998 to reduce wear and the incidence of revision resulting from osteolysis. A second motivation for developing these polyethylenes was to reduce oxidation, which had been associated with short-term clinical failures after gamma sterilization in air and long-term shelf aging in air. However, the strategies for achieving wear reduction and oxidation resistance varied among orthopaedic implant producers. One approach, known as annealing, involved a single thermal treatment below the crystalline melt transition in polyethylene to preserve crystallinity and mechanical properties [79] . When combined with terminal gamma sterilization in an inert environment, this strategy resulted in a material containing elevated residual free radicals with the potential to oxidize in vivo. A second approach to polyethylene formulation, referred to as remelting, involved thermal treatment above the melt transition [95, 103] . This second strategy resulted in a material with undetectable free radicals but at the expense of reduced crystallinity and lower material properties.
Systematic reviews of outcomes involving HXLPEs are rare [102] . Mu et al. [102] performed a systematic review of radiographic outcomes for HXLPE in hip arthroplasty, but the review only included the findings of eight prospective randomized studies. Our present study is composed of four parts, each addressing one of the following questions: (1) What is the historical context for first-generation HXLPEs used in hip and knee arthroplasty? (2) How do study factors (eg, followup, radiographic wear methodology) and implant design factors (eg, HXLPE formulation, head size, head material) influence radiographic wear outcomes for the hip? (3) How do implant design factors influence radiographic osteolysis outcomes in the hip? (4) How do implant design factors influence radiographic outcomes in the knee?
Search Strategy and Criteria
The history and development of polyethylene biomaterials for orthopaedics spans five decades and is recorded in research and review articles, conference proceedings, and several books [34, 74, 76, 77, 139] . A MEDLINE search was considered impractical to summarize in a concise review and would also neglect the historical contributions of key abstracts at national conferences that were never published in journal articles. Instead, the references for the first part of this review were drawn from the bibliographies of the UHMWPE Biomaterials Handbook [76] , which is a comprehensive monograph on the history of this subject.
To answer the remaining research questions for this review, an advanced PubMed search was performed of the hip and knee arthroplasty literature. Title and abstract fields were queried using the following precise syntax: . These search terms were chosen based on the brand names of the first-generation, HXLPEs introduced for total joint arthroplasty starting in 1998 (Table 1) . For the purposes of this review, secondgeneration crosslinked polyethylenes, fabricated by mechanical annealing [80] , sequential annealing [43] , and diffusion of vitamin E [112] , were excluded because of their recent introduction and the absence of a body of published journal studies documenting their clinical performance, warranting a systematic review. The search also included terms for crosslinked and polyethylene or UHMWPE. The search was also narrowed to identify wear or osteolysis or penetration studies published in English. Using these criteria, 391 articles published after January 1, 2001, were obtained on September 11, 2010.
By reviewing titles and abstracts, duplicates were excluded, as well as studies with less than 2 years of radiographic followup for either wear or osteolysis, resulting in 44 articles for the hip and two articles for the knee (Fig. 1 ) for detailed evaluation for systematic review and evaluation of inclusion and exclusion criteria for the weighted-averages analysis.
Two reviewers (JDP, HAG) extracted information from 44 hip studies independently using a standardized extraction form. Information extracted included study design, number of patients, patient demographic information (age, gender, weight, body mass index), followup time, device design factors (acetabular liner material, femoral head size, femoral head material), patient diagnoses, and radiographic wear outcome measures (polyethylene two-dimensional [2D] total linear penetration rates, methodology for femoral head penetration assessment, incidence of osteolysis). Extracted data were compared, and in the case of disagreements, original data were rechecked by both investigators and resolved by discussion and consensus with the first author (SMK). All the data extracted from these 44 hip studies can be found in Appendix 1 (supplemental materials are available with the online version of CORR). The data for the two knee studies were sufficiently different from the hip results that we summarized them independently later in this review.
By inspecting the extracted data, we determined sufficient information was available to compare femoral head penetration and osteolysis outcomes among a subset of the reported THA studies. Specifically, 2D linear penetration rates were pooled from randomized controlled trials (RCTs) and prospective and retrospective cohort studies with comparable outcome measures to conduct a weightedaverages analysis using a random-effects model in the Comprehensive Meta-analysis TM Version 2.2 software (Biostat, Englewood, NJ). The 28 studies included in the weighted averages comprised nine RCTs and 19 observational cohort studies.
Studies reporting duplicate trial data or lacking comparable outcome assessment were excluded from the weighted-averages analysis. Five studies were excluded based on clinical assessments of only a bedding-in rate or a steady-state wear rate. We identified one cohort study directly comparing femoral penetration among different HXLPE formulations [137] , but this study was excluded from our weighted-averages analysis because it only reported steady-state penetration rates. Similarly, Calvert et al. [22] excluded the bedding-in penetration rate and reported only the mean steady-state radiographic penetration rates from 6 months to 4 years. Another study excluded from the weighted-averages analysis was by Fukui et al. [45] , which did not separate out radiographic outcomes by HXLPE formulation, implying the femoral head penetration behavior was similar between the two groups. Other studies excluded from the analysis included Miyanishi et al. [ [39] were all cases of multiple publications on the same study. Only the most recent study [58] was included in the analysis because it contained the data from the earlier cohort.
Further analysis was conducted to determine whether device design (femoral head material, femoral head size, HXLPE formulation) or study design factors (study type, methodology to assess wear, followup time) influenced reported radiographic penetration rates. The continuous data for each of the factors listed were converted to dichotomous categorical data (Table 1) . Additional subgroup analysis evaluated the standardized difference in means (Hedge's g statistic) of 2D linear penetration rates in RCTs and cohort studies between the UHMWPE and HXLPE groups using a random-effects model. A subgroup analysis was also conducted to determine whether patient factors, device design factors, or study factors influenced the standardized difference in means. For analysis of the incidence of osteolysis in patients with conventional and HXPLE liners, observational cohort studies and RCT studies were combined and the pooled odds ratio was estimated using a random-effects model. Only studies with an average followup of at least 5 years were considered. A subgroup analysis was also conducted to determine whether patient factors, device design factors, or study factors influenced the pooled odds ratio for osteolysis.
History and Development of HXLPE
A full recounting of the historical events leading up to the ''discovery'' of polyethylene for hip arthroplasty in 1962 by Sir John Charnley and his engineering associate, Harry Craven, can be found in Charnley's monograph [27] and biography [135] , but it is instructive to briefly recall UHMWPE arrived in orthopaedics by chance rather than by design. Indeed, polyethylene was not Charnley's first, or even his second, choice as a bearing material for his lowfriction arthroplasty [25, 26] . It was not until after the catastrophic clinical failure of polytetrafluoroethylene (PTFE) that Charnley sought bearing material alternatives, and his initial choices were glass-filled variants of PTFE [27] . Were it not for the curiosity of Harry Craven, a technician working for Charnley at the time, UHMWPE would not have been wear tested [135] . When Charnley saw the superior wear performance of polyethylene compared with PTFE, he tested particles in his own thigh before allowing its use as a bearing material for joint arthroplasty [26] .
Charnley can be credited not only with the low-friction design principle for hip arthroplasty incorporating polyethylene [27] but also with recommending the use of gamma sterilization for polyethylene components [28] . Gamma radiation continues to be an effective and convenient method for sterilizing joint arthroplasty materials [65] , including polyethylene [75] . Charnley personally advocated gamma sterilization because it was the method used for the implants in his hospital [28] . Charnley saw little benefit to alternative sterilization methods, and he expressed these opinions forcefully in his personal correspondence [28] .
Charnley's advocacy of gamma radiation sterilization would later prove to be a double-edged sword. On the one hand, the crosslinking imparted by a single sterilization dose (25-40 kGy) of gamma radiation substantially improved its wear resistance [29, 55] and contributed to the long-term clinical success of the metal-on-polyethylene wear couple used in hip and knee arthroplasty to this day. Gamma sterilization in the presence of air also had a drawback in that it rendered the polymer vulnerable to oxidation before implantation [81, 113] and during in vivo exposure [30, 36, 78, 82, 129] . It would take decades, however, for gamma sterilization in air to be challenged as the industry standard for polyethylene, because the deleterious effects of oxidation in polyethylene take many years to manifest [81] .
Orthopaedic bearing designs incorporating gamma-airsterilized polyethylene proved to be more robust and reliable than other early alternatives, including first-generation metal-on-metal of the 1960s [4, 94, 120] and ceramic-onceramic bearings of the 1970s [17] . Difficulty in controlling the tolerances of early metal-on-metal hips has been hypothesized to result in seizure of some metal bearings culminating in early loosening [72] , whereas first-generation alumina components were prone to unacceptably high fracture rates [141] . Orthopaedic manufacturers clinically introduced carbon-fiber-reinforced UHMWPE (Poly II TM ; Zimmer, Inc, Warsaw, IN) [1, 33, 143] and high-pressure crystallized UHMWPE (Hylamer 1 ; DePuy Orthopaedics, Inc, Warsaw, IN) [23, 86] in the 1970s and 1980s, respectively. Both of these attempts at polyethylene innovation also failed to win clinical acceptance due to shortterm failures. In the case of Poly II TM , early failures were attributable to poor fiber-matrix adhesion and manufacturing reliability [33, 98] . In the case of Hylamer 1 , oxidation after gamma sterilization in air proved to be the Achilles heel for this material [70, 125] . Thus, it was not that orthopaedic researchers were unable to innovate new bearing concepts after the introduction of polyethylene. Manufacturing and materials science before the 1990s proved insufficient to engineer orthopaedic bearings of greater reliability than metal-on-polyethylene.
During the 1990s, clinical concern about osteolysis and loosening of joint arthroplasties prompted a shift in the perception of polyethylene among orthopaedic researchers and surgeons [59, 67, 123, 138] . Polyethylene used in orthopaedics was subjected to greater scrutiny than ever before in terms of its manufacturing processes, sterilization techniques, wear mechanisms, and degradation chemistry. Research studies from this time period identified poor consolidation during manufacturing, wear, and poststerilization oxidation of polyethylene as key factors limiting the longevity of total joint arthroplasties [81, 86, 113, 119, 145] . As a result, a number of improvements were implemented in the 1990s for the way medical-grade polyethylene was used in orthopaedics. These changes included improvements in the production of the resin or powder by no longer including calcium stearate [81, 96, 124, 130] , manufacturing process optimization by compression molding and ram extrusion to eliminate consolidation defects [81, 86, 87, 115] , and a shift away from gamma sterilization in air to either gas sterilization or gamma sterilization in a low-oxygen environment [16, 30, 31, 81, 96, 105, 113, 117, 118, 128, 129, 136] . In retrospect, among these advancements, the transition away from gamma sterilization in air was perhaps the most meaningful in terms of prevention of short-term oxidation-related failures observed in knee arthroplasty [32, 93] .
The controversy surrounding polyethylene sterilization methods in the 1990s resulted in some manufacturers adopting gas sterilization by ethylene oxide or gas plasma [81, 117] . Although these implants effectively avoided the problems associated with oxidative degradation during shelf storage, the polyethylene was also not crosslinked by radiation [81] . As a result, comparative studies in hip simulator studies [96] and in radiographic wear studies showed higher wear rates for the uncrosslinked, gassterilized components when compared with gammasterilized controls, even after adjusting for poststerilization shelf life [63] . Because of its inferior wear resistance, the motivation to pursue uncrosslinked, gas-sterilized polyethylene for hip arthroplasty waned with the advent of HXLPE starting in the late 1990s.
In contrast, the use of gas-sterilized, uncrosslinked UHMWPE continues in TKA, because pitting, delamination, and fracture resistance were the dominant modes of concerning knee wear during the 1980s and 1990s [7-9, 15, 30, 136, 140, 142, 145] . In particular, several retrieval studies published in the 1990s showed ethylene oxide gassterilized knee implants effectively eliminated delamination when compared with gamma-sterilized components [30, 136, 140] , and these retrieval observations were subsequently confirmed in vitro by wear studies [11, 116] . Furthermore, seminal work on the fatigue and fracture behavior of highly crosslinked and remelted UHMWPEs in the late 1990s raised questions about the suitability of these materials for knee arthroplasty as a result of the loss in mechanical properties with increasing doses of radiation [6, 7] . For these historical reasons, gas-sterilized, uncrosslinked tibial inserts remain in clinical use today as one of the options among gamma-inert sterilization and HXLPE knees.
Despite progress in understanding the reasons underlying wear and oxidation, dissatisfaction with polyethylene performance was sufficient to encourage some members of the orthopaedic community to develop alternatives for hip arthroplasty [3, 14, 24, 40, 47, 107, 126] . Thus, orthopaedic manufacturers invested substantial resources in the commercialization of second-generation metal-on-metal [3, 24, 40] and ceramic-on-ceramic [14, 47, 107, 126] hip bearings during the 1990s, culminating in the growth in the adoption of these bearings at the start of the 21st century [18] . Concurrently, polyethylene researchers at multiple institutions around the world confirmed the finding that elevated doses of radiation crosslinking would reduce wear rates by an order of magnitude during in vitro hip simulator testing [95, 103, 133] . Clinical researchers in Japan and South Africa reported successful long-term case series initiated in the 1970s in which polyethylene had been exposed to elevated doses of gamma radiation [56, 109, 111] and silane chemistry [144] . Researchers also found thermal processing after radiation could influence the mechanical properties and oxidative resistance of the polymer [95, 103] . Taken together, these advances formed the basis for the first generation of radiation crosslinking and thermal stabilization technology and would usher in a renaissance of innovation for polyethylene biomaterials.
Starting in the late 1990s, the polyethylene research community turned its full attention to understanding and standardizing radiation crosslinking, whether by gamma radiation or electron beam irradiation, when combined with annealing and remelting thermal treatments [12, 53, 54, 68, 81, 84, 95, 97, 103, 134, 146] . In parallel with the expansion of scientific inquiry, the scope and number of international standards related to medical-grade UHMWPE increased. In 2003, the American Society for Testing and Materials (ASTM) convened a symposium dedicated to standardization of test methods related to highly crosslinked and thermally treated UHMWPE [77] , and by 2006, members of the standards community had reached a consensus on a guide for characterizing the properties for this family of biomaterials [2] . Whereas medical-grade UHMWPE and its properties could be specified by one standard in the mid-1990s, 10 standards in ASTM have been published to date related to UHMWPE biomaterials.
In summary, most technical aspects of first-generation HXLPE production are now covered by international consensus standards, and these polyethylene biomaterials represent the current, clinical state of the art. Starting around 2005, a second generation of HXLPE was developed using alternative methods to stabilize the polymer [43, 80, 112] . These newer polyethylenes have not yet firmly established a long-term clinical track record and are beyond the scope of the present review. Next we turn to the radiographic outcomes of first-generation HXLPEs in the hip.
Systematic Review of Femoral Head Penetration Studies for HXLPEs in Hip Arthroplasty
The weighted-averages analysis of femoral head penetration rate in HXLPE liners resulted in a mean penetration rate of 0.042 mm/year (Fig. 2 ) based on 28 studies (n = 1503 hips). Among conventional UHMWPE liners, the pooled weighted average was 0.137 mm/year (Fig. 3 ) based on 18 studies (n = 695 hips). Comparing conventional UHMWPE and HXLPE using a random-effects model and illustrated by a forest plot (Fig. 4) , available data support crosslinked polyethylene over conventional polyethylene.
Methodologic differences in the studies contributed substantially to the interstudy variability in femoral head penetration rates. We observed a difference in the weighted average of the total linear penetration rates of patients receiving HXLPE with a followup of 5 years or less (0.055 mm/year; 95% confidence interval [CI], 0.042-0.068) and greater than 5 years (0.034 mm/year; 95% CI, 0.025-0.042).
Additionally, the effect of the methodology (ie, Martell) was used to assess radiographic penetration on the overall penetration rates for conventional and HXLPE and calculated the weighted average as 0.036 mm/year (95% CI, 0.026-0.045) for Martell and 0.048 mm/year (95% CI, 0.039-0.058) for all the others. Among studies reporting results for conventional liners, the weighted-average linear penetration rate was calculated as 0.145 mm/year (95% CI, 0.100-0.191) and 0.125 mm/year (95% CI, 0.105-0.144) when radiographic penetration was assessed using the Martell methodology and other available methodology, respectively. These methodologic variations must be considered when interpreting the results of studies summarized by HXLPE formulation ( Table 2 ).
The weighted-average mean 2D penetration rate for different HXLPE formulations ranged from 0.023 mm/year (Durasul) to 0.063 mm/year (Aeonian) ( Table 2 ). Thus, the variation among formulations (on the order of 0.01 mm/year or less) is comparable to variations attributable to methodologic differences between the studies. We identified only one study in which two HXLPE formulations were directly compared using the same followup period and radiographic methodology. Whittaker et al. [137] compared radiographic outcomes in two cohorts of patients receiving total hip systems manufactured by Smith & Nephew Inc (Memphis, TN) (n = 47 cases including an XLPE liner) or Zimmer Inc (n = 36 cases including Longevity 1 liners) and with minimum 5-year followup. The authors did not observe a difference in steady-state 2D penetration rates between the XLPE or Longevity 1 cohorts.
The weighted averages of the penetration rates for small and large cobalt-chromium femoral heads into HXLPE liners were 0.048 mm/year (95% CI, 0.038-0.058) and 0.027 mm/year (95% CI, À0.010-0.064), respectively ( Table 3 ). Bragdon et al. [19] compared linear penetration rates of different heads sizes with Durasul 1 liners (Zimmer Inc) after a 3.7-year followup and found the penetration rates were 0.03 mm/year in 28-mm heads and 0.01 mm/ year in 32-mm heads. Hammerberg et al. [58] reported a linear penetration rate after an average 3.6-year followup of 0.023 and 0.021 mm/year for 28-to 32-mm and 38-to 44-mm femoral heads on Durasul 1 liners. With a longer mean followup time of 5.7 years, Lachiewicz et al. [83] reported linear penetration rates of 0.06, 0.032, 0.011, and 0.075 mm/year for 26-, 28-, 32-, and 36-to 40-mm heads, respectively, on Longevity 1 liners. An RCT by Bragdon et al. [21] reported linear penetration rates of 0.020 and 0.005 mm/year for 28-and 38-mm heads, respectively, with Durasul 1 and Longevity 1 liners after a followup of 6.9 years. The overall weighted average of the linear penetration rate for metal (primarily cobalt-chromium) femoral heads on HXLPE was calculated as 0.038 mm/year (95% CI, 0.032-0.045) from eight RCTs and 16 cohort studies. An RCT by Ise et al. [66] reported a linear penetration rate of 0.068 (standard error, 0.009) for stainless steel on HXLPE.
The overall weighted-average penetration rate of six studies with ceramic femoral heads on HXLPE liners was 0.058 mm/year (95% CI, 0.040-0.076) ( Table 4 ). An RCT study by Kim et al. [71] reported a 2D linear penetration rate for alumina on HXLPE as 0.06 mm/year (standard error, 0.003). Similarly, Oonishi et al. [110] reported a penetration (Table 4) .
Weighted-averages Analysis of Studies Reporting Osteolysis Outcomes for HXLPEs in Hip Arthroplasty
The incidence of osteolysis in patients with UHMWPE liners and HXPLE liners was analyzed by calculating odds ratios from individual cohort (n = 8) and RCT (n = 1) studies with 5-year minimum followup (Fig. 5) . The studies were combined and the pooled odds ratio was estimated to be 0.131 (95% CI, 0.064-0.268) using a random-effects model, indicating the incidence of osteolysis is 87% lower in patients with HXLPE liners when compared with patients with conventional polyethylene liners. Subgroup analysis was also conducted for patient demographics, study design, and device design factors ( Table 5 ). The variation in the odds ratio for osteolysis was not attributable to any of the factors we considered.
Summary of Radiographic Outcome Studies for HXLPEs in Knee Arthroplasty
Only two knee studies were identified in the literature search of HXLPEs in total joint arthroplasty [62, 99] , insufficient for a systematic review and analysis. These studies are nevertheless summarized briefly for completeness and to document the current state of the art in the literature for HXLPEs used in knee arthroplasty. Hodrick et al. [62] retrospectively studied the clinical and radiographic outcomes for Durasul 1 and gamma-inertsterilized UHMWPE in the Natural-Knee 1 (Zimmer Inc), which is a cruciate-retaining design. One hundred consecutive patients were selected for each cohort based on the date of availability of the HXLPE at their institution in February 2001. Between 30% and 34% of the patients in both groups received cement fixation. The mean followup was 7.6 years for the conventional cohort and 6.3 years for the HXLPE cohort. There were nine revisions in the conventional cohort and five in the HXLPE cohort. The revision rates of the two cohorts were similar.
Minoda et al. [99] compared the clinical and radiographic outcomes for Prolong 1 (Zimmer Inc) and gamma-inert-sterilized UHMWPE in the NexGen 1 cruciateretaining knee design (Zimmer Inc). The single-institution study design included two consecutive series (n = 89 HXLPE, n = 113 conventional polyethylene) performed by the same surgical team with the same operative technique. Among implant factors, only the tibial insert material differed between cohorts. At 2-year followup, no differences were observed in ROM, knee alignment, and Knee Society score. There were no revisions and no radiographic observations of osteolysis. * Values are expressed as mean, with standard error in parentheses; 2D = two-dimensional; HXLPE = highly crosslinked polyethylene; RCT = randomized controlled trial; COH = prospective or retrospective cohort study. Fig. 5 The odds ratio for osteolysis (conventional versus HXLPE) was 0.131 across nine studies. Note an odds ratio of less than 1 implies a lower risk of osteolysis for HXLPE relative to conventional UHMWPE. PE = polyethylene. 
Discussion
The primary intent of this review was to provide a concise overview of the major themes in polyethylene biomaterials, including the development of HXLPE. For three decades after its introduction by Charnley for metal-on-plastic lowfriction arthroplasty, advances in polyethylene technology were relatively modest. The development of HXLPEs in the late 1990s ushered in a period of scientific growth and renewed interest in further optimizing and standardizing the polymer for hip and knee arthroplasty. The second and third aims of this study were to systematically review hip arthroplasty studies reporting radiographic wear and osteolysis outcomes of HXLPEs. Available evidence in 44 primary research studies uniformly supports elevated radiation crosslinking technology as an effective method to reduce femoral head penetration and osteolysis in THA; however, the improvement in long-term survivorship remains to be demonstrated. Based on currently available literature, reduction in femoral head penetration or osteolysis risk is not supported for large-diameter ([ 32 mm) metallic femoral heads or ceramic femoral heads of any size based on currently available literature. The fourth aim was to systematically review the radiographic outcomes of HXLPEs used in the knee. Because only two studies reporting clinical outcomes of HXLPEs in knee arthroplasty could be identified, it remains too early to perform a meta-analysis of the knee literature. This review and the literature are limited. First, it was not feasible to exhaustively cite all the relevant scientific and preclinical testing references for each type of commercially available polyethylene formulation. The interested reader should appreciate a detailed treatment of polyethylene technology over a five-decade period can fill an entire textbook [76] . Second, the historical focus in the first part of the review precluded a formal, Cochrane-style search strategy. Third, the review of radiographic wear rates and incidence of osteolysis in hip and knee arthroplasty was limited to polyethylene formulations used by major manufacturers and documented in journal publications. Fourth, we accepted both prospective randomized studies and cohort studies for our weighted-averages analysis of wear and osteolysis. Fifth, this review is based on first-generation HXLPEs, and more recent secondgeneration HXLPEs were excluded. Sixth, as highlighted by our own analysis, methodologic variations among different studies are at least as great as the differences between HXLPE formulation, femoral head size, and femoral head material. Seventh, the reported outcomes of radiographic wear analysis are heterogeneous across studies (ie, 2D versus three-dimensional penetration rates, overall versus steady-state penetration rates), greatly complicating interstudy comparisons of findings such as the present review. Thus, for all of these reasons, our results are not intended to be interpreted as a formal metaanalysis but a quantitative systematic review.
Although encouraging, the story is by no means over for first-generation HXLPEs. One decade after their clinical introduction, our knowledge of the clinical failure modes and reasons of revision for first-generation HXLPEs remains extremely limited. For annealed polyethylene, which contains residual free radicals, in vivo oxidation has been observed at the rim [78] , and rim delamination has been identified in case studies of chronic instability and impingement [35] . The mechanical properties and oxidation of the bearing surface in retrieved annealed bearings have not yet shown evidence of degradation with implantation [78] , suggesting the femoral head reduces in vivo oxidation at this location. For remelted polyethylenes, rim fracture has been reported in several case studies requiring revision of the bearing [42, 57, 58, 101, 131] . Common threads among rim fracture case studies include thin remelted liners, sometimes with an elevated rim, and vertical orientation (malpositioning) of the shell. Evidence of rim fatigue and fracture has been observed in remelted polyethylene; however, the prevalence of this failure mode remains poorly understood. Although not generally associated with revision, the findings of rim oxidation (in annealed liners) and cracks (in remelted liners) provide motivation to continue to monitor first-generation highly crosslinked materials into their second decade of service, because the long-term clinical importance of these observations remains unclear. Furthermore, evidence of low but measurable oxidation at the bearing surface of retrieved remelted liners has as yet unknown implications for the second decade of service [88] . These unanswered questions provide motivation for ongoing research on the long-term stability and mechanical performance of first-generation polyethylene materials.
From a clinical perspective, many unanswered questions for first-generation polyethylene biomaterials relate to component design, specifically as they relate to thin hip liners with large-diameter femoral heads, the effectiveness of ceramic femoral heads, and inserts for knee arthroplasty. Based on the documented success of HXLPEs with 28-mm femoral heads (Table 3) , over the past decade, there has been a shift to use larger head sizes with an effort to reduce the incidence of dislocation. Nevertheless, to date, less than a handful of clinical studies have reported data for HXLPE studies based on 32-mm or greater femoral head sizes [19] ( Table 3 ). In 2004, a survey of orthopaedic manufacturers found the largest head diameters offered in the United States ranged from 36 to 44 mm and the thinnest hip bearings ranged from 5 to 6 mm [74] . When the study was repeated in 2009, the largest head diameters ranged from 36 to 48 mm and the thinnest hip bearings ranged from 3.8 to 6 mm [76] . Thus, concerns about the minimum thickness of polyethylene are currently perceived to limit the introduction of acetabular liners with femoral head sizes greater than 48 mm. This systematic review identified numerous studies documenting the clinical performance of HXLPEs for hip arthroplasty, but only two clinical outcomes studies were identified for HXLPE use in the knee [62, 99] . The authors of both knee studies emphasized their research demonstrated the short-term safety of HXLPE in the knee. However, because neither study quantified femoral component penetration or detected osteolysis, it is not yet possible to judge the clinical efficacy and value of HXLPE in knee arthroplasty. Initially, only two manufacturers (Sulzer, Winterthur, Switzerland; and Zimmer Inc) were distributing highly crosslinked tibial inserts in the United States due to concerns about the reduced fatigue and fracture behavior, especially with remelted polyethylenes. Over the past 5 years, acceptance of crosslinking technology for knees has increased substantially, but still only three of five major orthopaedic manufacturers currently offer first-generation highly crosslinked tibial inserts [76] . In light of the crucial and ever-expanding role that polyethylene biomaterials play in knee arthroplasty and the perception among certain health economists that the use of HXLPE for TKA is an expensive ''premium'' technology of questionable value [50] , the currently limited clinical evidence supporting the use of HXLPEs for the knee is remarkable.
The next evolutionary phase of polyethylene biomaterials development, which is ongoing, has focused on techniques to stabilize highly crosslinked polyethylene without sacrificing material properties by remelting [43, 80, 112] . Given the 10-year followup that has been necessary to assure members of the orthopaedic community of the long-term effectiveness of first-generation HXLPEs, it may seem premature for polyethylene scientists to have already moved on to propose new generations of polymer technology for hip and knee bearings. It remains to be determined what clinical benefits, if any, will be provided by second-generation polyethylene technologies beyond those already afforded by first-generation HXLPE.
